Company Data
Innoviva Inc.
Ticker
INVA
Current Price
$21.03 -0.61%
Market Cap
$1.6B
Price Target
Refer to Report
Volume
483.2K
52wk Range
$16.52 - $22.76
Overview
Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance’s respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline.